Skip to main content
Clinical Trials/NL-OMON47690
NL-OMON47690
Completed
Not Applicable

on-invasive assessment of lung remodelling in patients with pulmonary arterial hypertension (PAH) using [18F]-FLT PET imaging. - Imaging the primary disease process in PAH

Vrije Universiteit0 sites36 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial ended prematurely

Registry
who.int
Start Date
TBD
End Date
January 9, 2020
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • 1\.Diagnosis of PAH, according to ESC/ERS guidelines (ref: Galie ERJ 2015\)
  • Unaffected BMPR2 mutation carrier
  • Normal control subjects
  • 2\. Age \>50 and \<80 years

Exclusion Criteria

  • \- Pregnant subjects
  • \- Claustrophobia
  • \- Inability to provide informed consent
  • \- In case of PAH patients: TLC \< 70%pred or radiographic evidence of interstitial lung disease
  • \- In case of BMPR2 mutation carriers and normal control subjects, one or more of the following: abnormal spirometry, TLC \< 70%, echocardiographic evidence of pulmonary hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials